nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA1—esophageal cancer	0.511	0.569	CbGaD
Methyclothiazide—CA2—esophageal cancer	0.387	0.431	CbGaD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA1—esophageal cancer	0.00824	0.116	CbGpPWpGaD
Methyclothiazide—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA1—esophageal cancer	0.0079	0.111	CbGpPWpGaD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—esophageal cancer	0.00754	0.106	CbGpPWpGaD
Methyclothiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—esophageal cancer	0.00693	0.0973	CbGpPWpGaD
Methyclothiazide—CA4—Reversible hydration of carbon dioxide—CA1—esophageal cancer	0.00655	0.092	CbGpPWpGaD
Methyclothiazide—CA2—Reversible hydration of carbon dioxide—CA1—esophageal cancer	0.00628	0.0882	CbGpPWpGaD
Methyclothiazide—CA4—Reversible hydration of carbon dioxide—CA2—esophageal cancer	0.00599	0.0841	CbGpPWpGaD
Methyclothiazide—CA1—Reversible hydration of carbon dioxide—CA2—esophageal cancer	0.0055	0.0773	CbGpPWpGaD
Methyclothiazide—CA2—exocrine gland—esophageal cancer	0.00121	0.107	CbGeAlD
Methyclothiazide—SLC12A1—epithelium—esophageal cancer	0.00118	0.105	CbGeAlD
Methyclothiazide—SLC12A3—lung—esophageal cancer	0.00098	0.0871	CbGeAlD
Methyclothiazide—CA4—neck—esophageal cancer	0.00093	0.0828	CbGeAlD
Methyclothiazide—CA2—neck—esophageal cancer	0.000771	0.0686	CbGeAlD
Methyclothiazide—Quinethazone—CA1—esophageal cancer	0.000716	0.0822	CrCbGaD
Methyclothiazide—Benzthiazide—CA1—esophageal cancer	0.000665	0.0765	CrCbGaD
Methyclothiazide—Cyclothiazide—CA1—esophageal cancer	0.000665	0.0765	CrCbGaD
Methyclothiazide—Diclofenamide—CA1—esophageal cancer	0.000661	0.0759	CrCbGaD
Methyclothiazide—Chlorothiazide—CA1—esophageal cancer	0.000661	0.0759	CrCbGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000636	0.00893	CbGpPWpGaD
Methyclothiazide—CA1—digestive system—esophageal cancer	0.000616	0.0548	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000582	0.00817	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000578	0.00811	CbGpPWpGaD
Methyclothiazide—CA4—trachea—esophageal cancer	0.00056	0.0498	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA1—esophageal cancer	0.000558	0.0641	CrCbGaD
Methyclothiazide—Quinethazone—CA2—esophageal cancer	0.000543	0.0623	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA1—esophageal cancer	0.000543	0.0623	CrCbGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000528	0.00742	CbGpPWpGaD
Methyclothiazide—CA2—epithelium—esophageal cancer	0.000525	0.0467	CbGeAlD
Methyclothiazide—CA2—bronchus—esophageal cancer	0.000517	0.046	CbGeAlD
Methyclothiazide—CA1—lung—esophageal cancer	0.000515	0.0458	CbGeAlD
Methyclothiazide—CA2—smooth muscle tissue—esophageal cancer	0.000506	0.045	CbGeAlD
Methyclothiazide—Cyclothiazide—CA2—esophageal cancer	0.000504	0.0579	CrCbGaD
Methyclothiazide—Benzthiazide—CA2—esophageal cancer	0.000504	0.0579	CrCbGaD
Methyclothiazide—Chlorothiazide—CA2—esophageal cancer	0.000501	0.0575	CrCbGaD
Methyclothiazide—Diclofenamide—CA2—esophageal cancer	0.000501	0.0575	CrCbGaD
Methyclothiazide—Trichlormethiazide—CA1—esophageal cancer	0.000484	0.0556	CrCbGaD
Methyclothiazide—CA4—digestive system—esophageal cancer	0.000482	0.0428	CbGeAlD
Methyclothiazide—CA2—trachea—esophageal cancer	0.000464	0.0413	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA2—esophageal cancer	0.000423	0.0486	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA2—esophageal cancer	0.000411	0.0472	CrCbGaD
Methyclothiazide—CA4—lung—esophageal cancer	0.000402	0.0358	CbGeAlD
Methyclothiazide—CA2—digestive system—esophageal cancer	0.000399	0.0355	CbGeAlD
Methyclothiazide—Respiratory distress—Capecitabine—esophageal cancer	0.000371	0.0364	CcSEcCtD
Methyclothiazide—Trichlormethiazide—CA2—esophageal cancer	0.000366	0.0421	CrCbGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000363	0.00509	CbGpPWpGaD
Methyclothiazide—CA1—lymph node—esophageal cancer	0.000352	0.0313	CbGeAlD
Methyclothiazide—Hyperuricaemia—Cisplatin—esophageal cancer	0.000345	0.0338	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000341	0.00479	CbGpPWpGaD
Methyclothiazide—Hypercalcaemia—Capecitabine—esophageal cancer	0.000339	0.0333	CcSEcCtD
Methyclothiazide—CA2—lung—esophageal cancer	0.000333	0.0297	CbGeAlD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000329	0.00463	CbGpPWpGaD
Methyclothiazide—Blood uric acid increased—Cisplatin—esophageal cancer	0.000326	0.0319	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000323	0.00454	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00031	0.00435	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000308	0.00433	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Carboplatin—esophageal cancer	0.000308	0.0302	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000296	0.00415	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000296	0.00415	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000293	0.00412	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00028	0.00393	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000278	0.00391	CbGpPWpGaD
Methyclothiazide—CA4—lymph node—esophageal cancer	0.000275	0.0245	CbGeAlD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000268	0.00377	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000268	0.00377	CbGpPWpGaD
Methyclothiazide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000257	0.0252	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000243	0.00342	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—BCL2—esophageal cancer	0.00024	0.00337	CbGpPWpGaD
Methyclothiazide—CA2—lymph node—esophageal cancer	0.000228	0.0203	CbGeAlD
Methyclothiazide—CA1—C-MYB transcription factor network—PTGS2—esophageal cancer	0.000228	0.0032	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000224	0.00315	CbGpPWpGaD
Methyclothiazide—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000212	0.0208	CcSEcCtD
Methyclothiazide—Cramp muscle—Cisplatin—esophageal cancer	0.000209	0.0205	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—CCND1—esophageal cancer	0.000206	0.00289	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000203	0.00286	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000203	0.00286	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000199	0.0028	CbGpPWpGaD
Methyclothiazide—Pancreatitis—Cisplatin—esophageal cancer	0.000197	0.0193	CcSEcCtD
Methyclothiazide—Photosensitivity—Capecitabine—esophageal cancer	0.000195	0.0191	CcSEcCtD
Methyclothiazide—Vascular purpura—Capecitabine—esophageal cancer	0.000191	0.0188	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00019	0.0186	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—EP300—esophageal cancer	0.000189	0.00266	CbGpPWpGaD
Methyclothiazide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000189	0.0186	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000185	0.00259	CbGpPWpGaD
Methyclothiazide—Vasculitis—Methotrexate—esophageal cancer	0.00018	0.0176	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000179	0.0175	CcSEcCtD
Methyclothiazide—Purpura—Capecitabine—esophageal cancer	0.000178	0.0174	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—MYC—esophageal cancer	0.000165	0.00232	CbGpPWpGaD
Methyclothiazide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000165	0.0162	CcSEcCtD
Methyclothiazide—CA4—Metabolism—BLVRB—esophageal cancer	0.000156	0.0022	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC52A3—esophageal cancer	0.000156	0.0022	CbGpPWpGaD
Methyclothiazide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000156	0.0153	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—esophageal cancer	0.000156	0.0153	CcSEcCtD
Methyclothiazide—CA2—Metabolism—BLVRB—esophageal cancer	0.00015	0.00211	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC52A3—esophageal cancer	0.00015	0.00211	CbGpPWpGaD
Methyclothiazide—Photosensitivity—Methotrexate—esophageal cancer	0.000145	0.0142	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SLC52A3—esophageal cancer	0.000144	0.00202	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—BLVRB—esophageal cancer	0.000144	0.00202	CbGpPWpGaD
Methyclothiazide—Malnutrition—Cisplatin—esophageal cancer	0.00014	0.0137	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000135	0.0132	CcSEcCtD
Methyclothiazide—Muscle spasms—Cisplatin—esophageal cancer	0.000134	0.0132	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000133	0.0131	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CA1—esophageal cancer	0.000133	0.00187	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC10A2—esophageal cancer	0.000133	0.00187	CbGpPWpGaD
Methyclothiazide—Pneumonia—Capecitabine—esophageal cancer	0.000133	0.013	CcSEcCtD
Methyclothiazide—Vision blurred—Cisplatin—esophageal cancer	0.000132	0.0129	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000131	0.0128	CcSEcCtD
Methyclothiazide—Jaundice—Capecitabine—esophageal cancer	0.000129	0.0126	CcSEcCtD
Methyclothiazide—CA2—Metabolism—CA1—esophageal cancer	0.000128	0.00179	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC10A2—esophageal cancer	0.000128	0.00179	CbGpPWpGaD
Methyclothiazide—Leukopenia—Cisplatin—esophageal cancer	0.000125	0.0123	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000124	0.00174	CbGpPWpGaD
Methyclothiazide—Agranulocytosis—Capecitabine—esophageal cancer	0.000123	0.0121	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SLC10A2—esophageal cancer	0.000122	0.00172	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CA2—esophageal cancer	0.000122	0.00171	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000119	0.00167	CbGpPWpGaD
Methyclothiazide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000114	0.0112	CcSEcCtD
Methyclothiazide—CA4—Metabolism—PLCE1—esophageal cancer	0.000113	0.00159	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADH7—esophageal cancer	0.000113	0.00159	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000112	0.00158	CbGpPWpGaD
Methyclothiazide—Erythema multiforme—Capecitabine—esophageal cancer	0.000112	0.011	CcSEcCtD
Methyclothiazide—CA1—Metabolism—CA2—esophageal cancer	0.000112	0.00157	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000112	0.011	CcSEcCtD
Methyclothiazide—Anorexia—Cisplatin—esophageal cancer	0.000109	0.0107	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ADH7—esophageal cancer	0.000108	0.00152	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLCE1—esophageal cancer	0.000108	0.00152	CbGpPWpGaD
Methyclothiazide—Pancreatitis—Methotrexate—esophageal cancer	0.000108	0.0106	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000108	0.00152	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADH7—esophageal cancer	0.000104	0.00146	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLCE1—esophageal cancer	0.000104	0.00146	CbGpPWpGaD
Methyclothiazide—Malnutrition—Capecitabine—esophageal cancer	0.000103	0.0101	CcSEcCtD
Methyclothiazide—Paraesthesia—Cisplatin—esophageal cancer	0.000102	0.01	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000101	0.00986	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ADH1B—esophageal cancer	9.92e-05	0.00139	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Cisplatin—esophageal cancer	9.92e-05	0.00973	CcSEcCtD
Methyclothiazide—Muscle spasms—Capecitabine—esophageal cancer	9.91e-05	0.00972	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—esophageal cancer	9.88e-05	0.00968	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	9.73e-05	0.00955	CcSEcCtD
Methyclothiazide—Vision blurred—Capecitabine—esophageal cancer	9.71e-05	0.00953	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ADH1B—esophageal cancer	9.51e-05	0.00134	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TYMP—esophageal cancer	9.48e-05	0.00133	CbGpPWpGaD
Methyclothiazide—Vertigo—Capecitabine—esophageal cancer	9.26e-05	0.00908	CcSEcCtD
Methyclothiazide—Leukopenia—Capecitabine—esophageal cancer	9.23e-05	0.00905	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CYP26A1—esophageal cancer	9.22e-05	0.0013	CbGpPWpGaD
Methyclothiazide—Agranulocytosis—Methotrexate—esophageal cancer	9.16e-05	0.00899	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ADH1B—esophageal cancer	9.12e-05	0.00128	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TYMP—esophageal cancer	9.09e-05	0.00128	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Cisplatin—esophageal cancer	9.02e-05	0.00885	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ALOX15—esophageal cancer	8.99e-05	0.00126	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP26A1—esophageal cancer	8.84e-05	0.00124	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TYMP—esophageal cancer	8.71e-05	0.00122	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALOX15—esophageal cancer	8.62e-05	0.00121	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TPI1—esophageal cancer	8.57e-05	0.0012	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTO1—esophageal cancer	8.57e-05	0.0012	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP26A1—esophageal cancer	8.48e-05	0.00119	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Cisplatin—esophageal cancer	8.41e-05	0.00825	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—esophageal cancer	8.33e-05	0.00817	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ALOX15—esophageal cancer	8.26e-05	0.00116	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Capecitabine—esophageal cancer	8.24e-05	0.00808	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GSTO1—esophageal cancer	8.22e-05	0.00115	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TPI1—esophageal cancer	8.22e-05	0.00115	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDOB—esophageal cancer	8.22e-05	0.00115	CbGpPWpGaD
Methyclothiazide—Asthenia—Cisplatin—esophageal cancer	8.19e-05	0.00803	CcSEcCtD
Methyclothiazide—Anorexia—Capecitabine—esophageal cancer	8.02e-05	0.00786	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.95e-05	0.00112	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GAPDH—esophageal cancer	7.91e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TPI1—esophageal cancer	7.88e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTO1—esophageal cancer	7.88e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDOB—esophageal cancer	7.88e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CRABP1—esophageal cancer	7.84e-05	0.0011	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Cisplatin—esophageal cancer	7.81e-05	0.00766	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—esophageal cancer	7.67e-05	0.00752	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GAPDH—esophageal cancer	7.59e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDOB—esophageal cancer	7.56e-05	0.00106	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Capecitabine—esophageal cancer	7.55e-05	0.00741	CcSEcCtD
Methyclothiazide—CA2—Metabolism—CRABP1—esophageal cancer	7.52e-05	0.00106	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GNG7—esophageal cancer	7.46e-05	0.00105	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Capecitabine—esophageal cancer	7.31e-05	0.00717	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GAPDH—esophageal cancer	7.27e-05	0.00102	CbGpPWpGaD
Methyclothiazide—Vomiting—Cisplatin—esophageal cancer	7.26e-05	0.00712	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—esophageal cancer	7.23e-05	0.00709	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.21e-05	0.00101	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CRABP1—esophageal cancer	7.21e-05	0.00101	CbGpPWpGaD
Methyclothiazide—Rash—Cisplatin—esophageal cancer	7.19e-05	0.00706	CcSEcCtD
Methyclothiazide—Constipation—Capecitabine—esophageal cancer	7.19e-05	0.00705	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—esophageal cancer	7.19e-05	0.00705	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GNG7—esophageal cancer	7.15e-05	0.001	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDH2—esophageal cancer	6.99e-05	0.000982	CbGpPWpGaD
Methyclothiazide—Vertigo—Methotrexate—esophageal cancer	6.89e-05	0.00676	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—esophageal cancer	6.87e-05	0.00674	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GNG7—esophageal cancer	6.86e-05	0.000963	CbGpPWpGaD
Methyclothiazide—Nausea—Cisplatin—esophageal cancer	6.78e-05	0.00665	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ALDH2—esophageal cancer	6.7e-05	0.000941	CbGpPWpGaD
Methyclothiazide—Urticaria—Capecitabine—esophageal cancer	6.68e-05	0.00655	CcSEcCtD
Methyclothiazide—Body temperature increased—Capecitabine—esophageal cancer	6.65e-05	0.00652	CcSEcCtD
Methyclothiazide—CA4—Metabolism—GSTT1—esophageal cancer	6.65e-05	0.000934	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2A6—esophageal cancer	6.57e-05	0.000923	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDH2—esophageal cancer	6.42e-05	0.000902	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTT1—esophageal cancer	6.37e-05	0.000895	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2A6—esophageal cancer	6.3e-05	0.000885	CbGpPWpGaD
Methyclothiazide—Anaphylactic shock—Methotrexate—esophageal cancer	6.26e-05	0.00614	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ENO1—esophageal cancer	6.23e-05	0.000875	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS1—esophageal cancer	6.23e-05	0.000875	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Capecitabine—esophageal cancer	6.2e-05	0.00608	CcSEcCtD
Methyclothiazide—CA4—Metabolism—PSME1—esophageal cancer	6.14e-05	0.000862	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PSME2—esophageal cancer	6.14e-05	0.000862	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Methotrexate—esophageal cancer	6.13e-05	0.00601	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GSTT1—esophageal cancer	6.11e-05	0.000858	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2A6—esophageal cancer	6.04e-05	0.000848	CbGpPWpGaD
Methyclothiazide—Asthenia—Capecitabine—esophageal cancer	6.04e-05	0.00592	CcSEcCtD
Methyclothiazide—CA2—Metabolism—PTGS1—esophageal cancer	5.97e-05	0.000839	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ENO1—esophageal cancer	5.97e-05	0.000839	CbGpPWpGaD
Methyclothiazide—Anorexia—Methotrexate—esophageal cancer	5.97e-05	0.00585	CcSEcCtD
Methyclothiazide—CA2—Metabolism—PSME2—esophageal cancer	5.89e-05	0.000827	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PSME1—esophageal cancer	5.89e-05	0.000827	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Capecitabine—esophageal cancer	5.76e-05	0.00564	CcSEcCtD
Methyclothiazide—CA1—Metabolism—PTGS1—esophageal cancer	5.73e-05	0.000804	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO1—esophageal cancer	5.73e-05	0.000804	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PSME1—esophageal cancer	5.64e-05	0.000793	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PSME2—esophageal cancer	5.64e-05	0.000793	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Methotrexate—esophageal cancer	5.62e-05	0.00551	CcSEcCtD
Methyclothiazide—Dizziness—Capecitabine—esophageal cancer	5.56e-05	0.00546	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—esophageal cancer	5.44e-05	0.00534	CcSEcCtD
Methyclothiazide—Vomiting—Capecitabine—esophageal cancer	5.35e-05	0.00525	CcSEcCtD
Methyclothiazide—Rash—Capecitabine—esophageal cancer	5.3e-05	0.0052	CcSEcCtD
Methyclothiazide—Dermatitis—Capecitabine—esophageal cancer	5.3e-05	0.0052	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CYP1B1—esophageal cancer	5.3e-05	0.000744	CbGpPWpGaD
Methyclothiazide—Headache—Capecitabine—esophageal cancer	5.27e-05	0.00517	CcSEcCtD
Methyclothiazide—CA2—Metabolism—CYP1B1—esophageal cancer	5.08e-05	0.000713	CbGpPWpGaD
Methyclothiazide—Nausea—Capecitabine—esophageal cancer	5e-05	0.0049	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CYP19A1—esophageal cancer	4.98e-05	0.0007	CbGpPWpGaD
Methyclothiazide—Urticaria—Methotrexate—esophageal cancer	4.97e-05	0.00488	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—esophageal cancer	4.95e-05	0.00485	CcSEcCtD
Methyclothiazide—CA1—Metabolism—CYP1B1—esophageal cancer	4.87e-05	0.000684	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP19A1—esophageal cancer	4.77e-05	0.000671	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Methotrexate—esophageal cancer	4.61e-05	0.00452	CcSEcCtD
Methyclothiazide—CA1—Metabolism—CYP19A1—esophageal cancer	4.58e-05	0.000643	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMOX1—esophageal cancer	4.54e-05	0.000638	CbGpPWpGaD
Methyclothiazide—Asthenia—Methotrexate—esophageal cancer	4.49e-05	0.00441	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ABCB1—esophageal cancer	4.36e-05	0.000613	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMOX1—esophageal cancer	4.36e-05	0.000612	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Methotrexate—esophageal cancer	4.28e-05	0.0042	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ABCB1—esophageal cancer	4.18e-05	0.000587	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMOX1—esophageal cancer	4.18e-05	0.000587	CbGpPWpGaD
Methyclothiazide—Dizziness—Methotrexate—esophageal cancer	4.14e-05	0.00406	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ABCB1—esophageal cancer	4.01e-05	0.000563	CbGpPWpGaD
Methyclothiazide—Vomiting—Methotrexate—esophageal cancer	3.98e-05	0.0039	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—esophageal cancer	3.95e-05	0.00387	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—esophageal cancer	3.94e-05	0.00387	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—esophageal cancer	3.92e-05	0.00385	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—esophageal cancer	3.72e-05	0.00365	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CREBBP—esophageal cancer	2.92e-05	0.00041	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CREBBP—esophageal cancer	2.79e-05	0.000393	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CREBBP—esophageal cancer	2.68e-05	0.000376	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NOS3—esophageal cancer	2.61e-05	0.000367	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NOS3—esophageal cancer	2.5e-05	0.000352	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NOS3—esophageal cancer	2.4e-05	0.000337	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS2—esophageal cancer	2.39e-05	0.000335	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS2—esophageal cancer	2.29e-05	0.000322	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS2—esophageal cancer	2.19e-05	0.000308	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—EP300—esophageal cancer	1.99e-05	0.000279	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—EP300—esophageal cancer	1.9e-05	0.000267	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—EP300—esophageal cancer	1.82e-05	0.000256	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CA—esophageal cancer	1.47e-05	0.000206	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CA—esophageal cancer	1.41e-05	0.000198	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CA—esophageal cancer	1.35e-05	0.00019	CbGpPWpGaD
